New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABBV;ABT;ALJ;ALDW;FB;WGP;WES;LRCX;WHF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
May 27, 2015
10:01 EDTABTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abbott (ABT) initiated with a Buy at Evercore ISI... Aldeyra (ALDX) initiated with a Buy at Janney Capital... Black Stone Minerals (BSM) initiated with a Neutral at Credit Suisse... Boston Scientific (BSX) initiated with a Buy at Evercore ISI... Cidara Therapeutics (CDTX) initiated with a Buy at BTIG... Coach (COH) initiated with an Underweight at BB&T... Diplomat Pharmacy (DPLO) initiated with an Outperform at Raymond James... EPIRUS (EPRS) initiated with a Buy at BTIG... Enviva (EVA) initiated with a Buy at Citigroup... General Finance Corp (GFN) initiated with an Outperform at Oppenheimer... Hortonworks (HDP) initiated with an Outperform at Oppenheimer... Jarden (JAH) initiated with a Buy at UBS... Kate Spade (KATE) initiated with a Buy at BB&T... Medtronic (MDT) initiated with a Hold at Evercore ISI... MoneyGram (MGI) initiated with a Neutral at Goldman... Opexa Therapeutics (OPXA) initiated with a Buy at Maxim... Paratek Pharmaceuticals (PRTK) initiated with a Buy at BTIG... Progenics (PGNX) initiated with a Buy at BTIG... Rite Aid (RAD) initiated with a Buy at Mizuho... St. Jude Medical (STJ) initiated with a Buy at Evercore ISI... Starwood Waypoint (SWAY) initiated with an Outperform at Wells Fargo... Talen Energy (TLN) initiated with a Hold at Deutsche Bank... Ulta Salon (ULTA) initiated with a Buy at Buckingham... Vipshop (VIPS) initiated with a Buy at Stifel... Virtu Financial (VIRT) initiated with a Neutral at Citigroup... Vista Outdoor (VSTO) initiated with a Buy at Wunderlich... ZELTIQ (ZLTQ) initiated with a Buy at Northcoast... eBay (EBAY) initiated with a Buy at Topeka.
09:38 EDTFBActive equity options trading on open
Subscribe for More Information
09:17 EDTFBFacebook's Oculus acquires Surreal Vision, terms not disclosed
Facebook-owned Oculus announced in a blog post yesterday the acquisition of Surreal Vision. Oculus explains, "Surreal Vision is one of the top computer vision teams in the world focused on real-time 3D scene reconstruction – generating an accurate representation of the real world in the virtual world. Great scene reconstruction will enable a new level of presence and telepresence, allowing you to move around the real world and interact with real-world objects from within VR." Reference Link
08:39 EDTFBSony purchases Optical Archive, WSJ reports
Subscribe for More Information
07:42 EDTABTAbbott initiated with a Buy at Evercore ISI
Target $54.
06:57 EDTABBVAbbVie enters into ASR with Morgan Stanley to repurchase $5B of stock
AbbVie (ABBV) said in a regulatory filing that on May 26, it entered into an accelerated share repurchase agreement with Morgan Stanley (MS) to repurchase $5B of AbbVie’s common stock. Morgan Stanley is expected to make an initial delivery of approximately 68 million shares of AbbVie’s common stock on May 27, which represents 90% of the prepayment amount divided by the closing price of AbbVie’s common stock on May 26. At settlement of the agreement, Morgan Stanley may be required to deliver additional shares of AbbVie’s common stock to AbbVie or, under certain circumstances, AbbVie may be required to deliver shares of its common stock or may elect to make a cash payment to Morgan Stanley. The total number of shares of AbbVie’s common stock to be repurchased under the agreement will be based on the daily volume-weighted average price of AbbVie’s common stock during the term of the transaction, less a discount and subject to adjustment pursuant to the terms of the agreement. The final settlement of the transactions under the agreement is expected to occur before the end of 4Q15 and may be accelerated at the option of Morgan Stanley.This agreement was entered into pursuant to AbbVie’s previously disclosed share repurchase authorization and in connection with AbbVie’s previously announced acquisition of Pharmacyclics, which was completed on May 26.
06:25 EDTABBVAbbVie reinstated with an Overweight at JPMorgan
JPMorgan reinstated its Overweight rating on shares of AbbVie and raised its price target for shares to $75 from $73. The firm views the valuation as "inexpensive" and views the Pharmacyclics acquisition as adding a "solid" growth platform.
06:13 EDTFBTech companies look for ways to fend off activist investors, WSJ reports
Subscribe for More Information
06:01 EDTFBSnapchat CEO says company 'needs to IPO," Business Insider reports
Subscribe for More Information
May 26, 2015
19:16 EDTABBVEnanta says may receive $30M milestone payment from AbbVie upon Japan approval
In reference to the release of GIFT-1 study data, Enanta (ENTA) stated that upon commercialization regulatory approval [sic] in Japan of AbbVie's (ABBV) treatment regimen related to GIFT-1, Enanta will be entitled to a $30M milestone payment from AbbVie. In addition, Enanta will be eligible to receive annually tiered royalties, ranging from the low double digits up to 20%, on AbbVie’s aggregate net sales of all paritaprevir-containing regimens, including 45% of AbbVie’s worldwide net sales of any two direct-acting antivirals regimen.
19:07 EDTABBVAbbVie presents phase 3 GIFT-I data, says achieved primary endpoint
Subscribe for More Information
18:32 EDTFBFacebook India offers content creators exclusivity deals, Economic Times says
Subscribe for More Information
16:01 EDTFBOptions Update; May 26, 2015
Subscribe for More Information
10:46 EDTABBVAnthem sued for denying coverage for Gilead's Harvoni, WSJ says
Subscribe for More Information
10:12 EDTLRCXLam Research management to meet with Pacific Crest
Subscribe for More Information
08:32 EDTABBVAbbVie completes acquisition of Pharmacyclics
Subscribe for More Information
08:03 EDTABBVInfinity Pharmaceuticals reports preclinical data for duvelisib
Subscribe for More Information
07:19 EDTFBFacebook being scrutinized on several fronts in Europe, NY Times reports
In recent months, several different European regulators have been examining facets of Facebook's (FB) operations and it remains to be seen whether the social network operator has learned from the past mistakes of companies such as Intel (INTC), Microsoft (MSFT) and Google (GOOG) in terms of navigating Europe’s legal system, said The New York Times. The European Union is looking into whether Facebook unfairly favors its own services, the region’s top court will issue a preliminary decision next month on whether Facebook can continue transferring user data between Europe and the U.S. and a number of EU data protection watchdogs are questioning Facebook’s privacy settings, the report noted. Reference Link
06:16 EDTABTAbbott to start selling G.M.O-free Similac Advance formula, NY Times reports
Subscribe for More Information
May 22, 2015
16:00 EDTFBOptions Update; May 22, 2015
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use